Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("type 2")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 14699

  • Page / 588
Export

Selection :

  • and

Type 2 diabetes : Gaining insight into the disease process using proteomicsMARIS, Michael; OVERBERGH, Lut; MATHIEU, Chantal et al.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 3, pp 312-326, issn 1862-8346, 15 p.Article

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetesNIELSEN, Loretta L; YOUNG, Andrew A; PARKES, David G et al.Regulatory peptides. 2004, Vol 117, Num 2, pp 77-88, issn 0167-0115, 12 p.Article

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithmsCHRISTENSEN, J. O; SANDBAEK, A; LAURITZEN, T et al.Diabetologia (Berlin). 2004, Vol 47, Num 9, pp 1566-1573, issn 0012-186X, 8 p.Article

Mechanisms of Type I and Type II PseudohypoaldosteronismFURGESON, Seth B; LINAS, Stuart.Journal of the American Society of Nephrology. 2010, Vol 21, Num 11, pp 1842-1845, issn 1046-6673, 4 p.Article

Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. CommentaryDAVIDSON, M. B; DAVIS, W. A; BRUCE, D. G et al.Diabetologia (Berlin). 2007, Vol 50, Num 3, issn 0012-186X, 497-499,510-515 [9 p.]Article

Physiopathologie du diabète de type 2 = Pathogenesis of type 2 diabetes mellitusGUILLAUSSEAU, P.-J; LALOI-MICHELIN, M.La Revue de médecine interne (Paris). 2003, Vol 24, Num 11, pp 730-737, issn 0248-8663, 8 p.Article

Circulating β-carotene levels and type 2 diabetes―cause or effect?PERRY, J. R. B; FERRUCCI, L; HATTERSLEY, A. T et al.Diabetologia (Berlin). 2009, Vol 52, Num 10, pp 2117-2121, issn 0012-186X, 5 p.Article

Factors affecting diabetes knowledge in Type 2 diabetic veteransMURATA, G. H; SHAH, J. H; ADAM, K. D et al.Diabetologia (Berlin). 2003, Vol 46, Num 8, pp 1170-1178, issn 0012-186X, 9 p.Article

Trends and Perspectives in the Development of Antidiabetic Drugs for Type 2 Diabetes MellitusLEE, Soo-Hyun; LEE, Jong-Keun; KIM, Ik-Hwan et al.Han'gug mi'saengmul saengmyeong gong haghoeji. 2012, Vol 40, Num 3, pp 180-185, issn 1598-642X, 6 p.Article

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia StudyALMGREN, P; LEHTOVIRTA, M; ISOMAA, B et al.Diabetologia (Berlin). 2011, Vol 54, Num 11, pp 2811-2819, issn 0012-186X, 9 p.Article

La glycémie postprandiale: Un paramètre à prendre en compte (aussi) dans le diabète de type 2CATARGI, Bogdan.Diabète & obésité. 2011, Vol 6, Num 53, pp 352-356, issn 1957-5238, 5 p.Article

Progress with thiazolidinediones in the management of type 2 diabetes mellitusMERIDEN, Terry.Clinical therapeutics. 2004, Vol 26, Num 2, pp 177-190, issn 0149-2918, 14 p.Article

Global guideline for type 2 diabetes : recommendations for standard, comprehensive, and minimal careDiabetic medicine. 2006, Vol 23, Num 6, pp 579-593, issn 0742-3071, 15 p.Article

Birthweight of offspring and paternal insulin resistance and paternal diabetes in late adulthood: cross sectional surveyWANNAMETHEE, S. G; LAWLOR, D. A; WHINCUP, P. H et al.Diabetologia (Berlin). 2004, Vol 47, Num 1, pp 12-18, issn 0012-186X, 7 p.Article

Presentation and course of Type 2 diabetes in youth in a large multi-ethnic cityZDRAVKOVIC, V; DANEMAN, D; HAMILTON, J et al.Diabetic medicine. 2004, Vol 21, Num 10, pp 1144-1148, issn 0742-3071, 5 p.Article

Le traitement intensif du diabète de type 2: que nous enseigne l'étude STENO 2?RUIZ, Juan.Revue médicale de la Suisse romande. 2004, Vol 124, Num 3, pp 125-127, issn 0035-3655, 3 p.Conference Paper

Prevention or delay of type 2 diabetesDiabetes care. Supplement. 2004, Vol 27, Num 1, pp S47-S54, issn 1064-9131Article

Screening for type 2 diabetesDiabetes care. Supplement. 2004, Vol 27, Num 1, pp S11-S14, issn 1064-9131Article

Diabète de type 2 : découverte de nouveaux gènes de prédispositionCASALONGA, Sabine.Biofutur (Puteaux). 2007, Num 279, issn 0294-3506, 12Article

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetesSCHRAUWEN, Patrick; HESSELINK, Matthijs K. C.Diabetes (New York, NY). 2004, Vol 53, Num 6, pp 1412-1417, issn 0012-1797, 6 p.Article

Type 2 diabetes mellitus: not quite exciting enough?ASHCROFT, Frances; RORSMAN, Patrik.Human molecular genetics (Print). 2004, Vol 13, pp R21-R31, issn 0964-6906, NS1Article

Prévention du diabète de type 2 : traiter ou ne pas traiter ? Telle est la questionSLAMA, Gérard.Diabétologie et facteurs de risque. 2003, Vol 9, Num 79, pp 187-190, issn 1267-6527, 4 p.Article

Freins à l'instauration d'une insulinothérapie en ambulatoire chez les patients diabétiques de type 2 : enquête auprès de vingt médecins généralistes en AlsaceILTIS, Céline.2012, 352 p.Thesis

Antihyperglycemic effects of stevioside in type 2 diabetic subjectsGREGERSEN, Søren; JEPPESEN, Per B; HOLST, Jens J et al.Metabolism, clinical and experimental. 2004, Vol 53, Num 1, pp 73-76, issn 0026-0495, 4 p.Article

Physical activity/exercise and type 2 diabetesSIGAL, Ronald J; KENNY, Glen P; WASSERMAN, David H et al.Diabetes care. 2004, Vol 27, Num 10, pp 2518-2539, issn 0149-5992, 22 p.Article

  • Page / 588